Related Experiment Video
Updated: May 3, 2026

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
Published on: January 31, 2020
The novel IGF-IR/Akt-dependent anticancer activities of glucosamine
Ki-Hoon Song, Ju-Hee Kang, Jong-Kyu Woo
1Gachon Institute of Pharmaceutical Science, Gachon University, Incheon 406-840, Republic of Korea. eyeball@hanmail.net.
Background:
Recent studies have shown that glucosamine inhibits the proliferation of various human cancer cell lines and downregulates the activity of COX-2, HIF-1α, p70S6K, and transglutaminase 2. Because the IGF-1R/Akt pathway is a common upstream regulator of p70S6K, HIF-1α, and COX-2, we hypothesized that glucosamine inhibits cancer cell proliferation through this pathway.
Methods:
We used various in vitro assays including flow cytometry assays, small interfering RNA (siRNA) transfection, western blot analysis, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays, reverse transcription-polymerase chain reaction, and in vivo xenograft mouse model to confirm anticancer activities of glucosamine and to investigate the molecular mechanism.
Results:
We found that glucosamine inhibited the growth of human non-small cell lung cancer (NSCLC) cells and negatively regulated the expression of IGF-1R and phosphorylation of Akt. Glucosamine decreased the stability of IGF-1R and induced its proteasomal degradation by increasing the levels of abnormal glycosylation on IGF-1R. Moreover, picropodophyllin, a selective inhibitor of IGF-1R, and the IGF-1R blocking antibody IMC-A12 induced significant cell growth inhibition in glucosamine-sensitive, but not glucosamine-resistant cell lines. Using in vivo xenograft model, we confirmed that glucosamine prohibits primary tumor growth through reducing IGF-1R signalling and increasing ER-stress.
Conclusions:
Taken together, our results suggest that targeting the IGF-1R/Akt pathway with glucosamine may be an effective therapeutic strategy for treating some type of cancer.
Insights
Glucosamine inhibits cancer cell growth by targeting the IGF-1R/Akt pathway. This natural compound reduces Insulin-like Growth Factor 1 Receptor (IGF-1R) stability, leading to cancer cell death and reduced tumor growth.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Glucosamine demonstrates inhibitory effects on various human cancer cell lines.
- It downregulates key signaling molecules including COX-2, HIF-1α, and p70S6K.
- The IGF-1R/Akt pathway is a known upstream regulator for these molecules, suggesting its role in glucosamine's action.
Purpose of the Study:
- To investigate the hypothesis that glucosamine inhibits cancer cell proliferation via the IGF-1R/Akt pathway.
- To elucidate the molecular mechanisms underlying glucosamine's anticancer activities.
Main Methods:
- Utilized in vitro assays: flow cytometry, siRNA transfection, western blot, MTT assays, RT-PCR.
- Employed in vivo xenograft mouse models to assess anticancer effects.
- Investigated molecular targets including IGF-1R and Akt phosphorylation.
Main Results:
- Glucosamine inhibited non-small cell lung cancer (NSCLC) cell growth.
- It negatively regulated IGF-1R expression and Akt phosphorylation, decreasing IGF-1R stability via proteasomal degradation.
- In vivo studies confirmed glucosamine's tumor growth inhibition by reducing IGF-1R signaling and increasing ER-stress.
Conclusions:
- Targeting the IGF-1R/Akt pathway with glucosamine shows therapeutic potential for certain cancers.
- Glucosamine's ability to induce IGF-1R degradation offers a novel strategy.
- Further research into glucosamine as a cancer therapeutic is warranted.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Mitogens and the Cell Cycle
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...

